Clinical Trial Update: Using Thermography to Assess the Affects of Sildenafil Cream, 3.6% [Phase 1]

View source ↗

Summary

A Phase 1 study by Daré Bioscience evaluating sildenafil cream, 3.6%, for sexual arousal disorder has completed, with thermography used to assess effects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Female Sexual Arousal Disorder

Drugs mentioned

• Sildenafil Cream, 3.6% (sildenafil)

Snippet

Sponsor: Daré Bioscience, Inc. | Conditions: Sexual Arousal Disorder | Phase 1 | Status: COMPLETED